KR840005428A - 4-아미노-6, 7-디메톡시퀴놀린 유도체의 제조방법 - Google Patents
4-아미노-6, 7-디메톡시퀴놀린 유도체의 제조방법 Download PDFInfo
- Publication number
- KR840005428A KR840005428A KR1019830003392A KR830003392A KR840005428A KR 840005428 A KR840005428 A KR 840005428A KR 1019830003392 A KR1019830003392 A KR 1019830003392A KR 830003392 A KR830003392 A KR 830003392A KR 840005428 A KR840005428 A KR 840005428A
- Authority
- KR
- South Korea
- Prior art keywords
- product
- alkyl
- compound
- formula
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/195—Radicals derived from nitrogen analogues of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 다음 일반식(Ⅱ)의 화합물을 폐환시키고 필요한 경우, (1) R이 4-벤질-피페라진-1-일 인 일반식(I)의 생성물을 R이 피페라지노인 화합물로 탈벤질화 시키는 반응; (2) R이인 화합물을 얻기 위해 R이 피페라지노인 일반식 R1COQ의 생성물을 일반식(I)의 화합물로 아실화 시키는 반응; (3) R이 피페라지노인 일반식(I)의 생성물을 일반식 R2.NCO의 이소시아네이트 또는 일반식 R2.NHCOCI의 카바모일 클로라이드와 반응시켜, R이인 화합물을 얻는 반응; (4) R이 피페라지노인 일반식(I)의 생성물을 일반식 R3OCOQ의 화합물과 반응시켜 R이인 화합물을 얻는 반응; (5) R이 피페라지노인 일반식(I)의 생성물을 화합물 YQ(여기서 Y는 질소를 함유한 방향족 헤테로사이클릭 그룹임)와 반응시켜 R이인 (여기서 Y는 상기와 같다)인 화합물을 얻는 반응; 중 하나 이상의 단계를 수행한 다음 필요한 경우, 생성물을 그의 약제학적으로 무독한 산부가염으로 전환시킴을 특징으로 하여 다음 일반식(I)의 화합물 또는 이의 약제학적으로 무독한 산부가염을 제조하는 방법.
-
- 상기에서 R은 -N(C1-C4알킬)2, 피페리디노 6,7-디메톡시-1,2,3,4,-테트라하이드로이소퀴놀-2-일 또는 일반식의 그룹을 나타내는데, 여기서 Y는 수소, C1-C6알킬, 아릴, 아릴로 치환된 C1-C4알킬, 또는 피페라지닐그룹의 인접한 질소원자에 탄소원자에 의해서 부착된 질소-함유 방향족 헤테로사이클릭 그룹을 나타내거나, -COR1, -CONHR2및 -COOR2중에서 선택된 것이며, R1은 C1-C6알킬, 아릴로 치환된 C1-C4알킬, C3-C6사이클로알킬, (C3-C6사이클로알킬) 메틸, 아릴, 스티릴 또는 헤테로사이클릭 그룹이며, R2는 C1-C6알킬, 아릴, 아릴로 치환된 C1-C4알킬, (C2-C4알케닐)메틸, C3-C6사이클로알킬 또는 (C3-C6사이클로알킬)메틸이며, R3는 C1-C6알킬, 아릴로 치환된 C1-C4알킬, α탄소원자 이외의 탄소원자에서 하이드록시로 치환된 C2-C4알킬, C3-C6사이클로알킬, (C3-C6사이클로알킬)메틸, (C2-C4알케닐)메틸, 또는 아릴이며, Q는 쉽게 이탈될 수 있는 것이다.
- 제1항에 있어서, R이 피페라지노이거나 4-벤질-피페라진-1-일이고 R1이 2-푸릴그룹인 제(2)단계가 포함되는 방법.
- 제1항에 있어서, R이 피페라지노이거나 4-벤질-피페라진-1-일이고 R1이 벤조-1,4-디옥산-2-일 그룹인 제(2)단계가 포함되는 방법.
- 제1항에 있어서, 생성물을 추가로 진한 황산과 반응시켜 R3가 하이드록시알킬-메틸그룹인 화합물을 제조하고, 필요한 경우, 이의 생성물을 약제학적으로 무독한 산부가염으로 전환시키는, R이 피페라지노이거나 4-벤질-피페라진-1-일이고 R3가 알케닐-메틸 그룹인 제(4)단계가 포함되는 방법.
- 제1항에 있어서, 생성물을 추가로 페놀 또는 아민과 반응기켜 Y가 페녹시-
- 또는 아미노-치환된 질소-함유 방향족 헤테로사이클릭 그룹인 화합물을 제조하고, 필요한 경우, 이의 생성물을 약제학적으로 무독한 산부가염으로 전환시키는, R이 이피페라지노 이거나 4-펜질-피페라진-1-일이고 Y가 클로로 치환된 질소-함유 방향족 헤테로사이클릭 그룹인 제(5)단계가 포함되는 방법.
- 제1항에 있어서, R이 6,7-디메톡시-1,2,3,4-테트라하이드로이소퀴놀린-2-일 그룹인 방법.
- ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8221457 | 1982-07-24 | ||
GB8221457 | 1982-07-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR840005428A true KR840005428A (ko) | 1984-11-12 |
KR880001315B1 KR880001315B1 (ko) | 1988-07-23 |
Family
ID=10531886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019830003392A KR880001315B1 (ko) | 1982-07-24 | 1983-07-22 | 4-아미노-6, 7-디메톡시퀴놀린 유도체의 제조방법 |
Country Status (26)
Country | Link |
---|---|
US (3) | US4656174A (ko) |
EP (1) | EP0100200B1 (ko) |
JP (1) | JPS5933264A (ko) |
KR (1) | KR880001315B1 (ko) |
AU (1) | AU548036B2 (ko) |
CA (1) | CA1255670A (ko) |
CS (1) | CS247073B2 (ko) |
DD (1) | DD211555A5 (ko) |
DE (1) | DE3371336D1 (ko) |
DK (1) | DK166821B1 (ko) |
ES (1) | ES8504131A1 (ko) |
FI (1) | FI78296C (ko) |
GR (1) | GR79603B (ko) |
HK (1) | HK32289A (ko) |
HU (1) | HU190907B (ko) |
IE (1) | IE55798B1 (ko) |
IL (1) | IL69311A (ko) |
NO (1) | NO171594C (ko) |
NZ (1) | NZ204996A (ko) |
PH (1) | PH19424A (ko) |
PL (1) | PL139498B1 (ko) |
PT (1) | PT77082B (ko) |
SG (1) | SG6489G (ko) |
SU (2) | SU1251801A3 (ko) |
YU (1) | YU42628B (ko) |
ZA (1) | ZA835355B (ko) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT384218B (de) * | 1985-12-04 | 1987-10-12 | Gerot Pharmazeutika | Verfahren zur herstellung von neuen chinazolin-derivaten |
GB8716972D0 (en) * | 1987-07-17 | 1987-08-26 | Pfizer Ltd | Treatment of cardiac arrhythmias |
GB8719378D0 (en) * | 1987-08-15 | 1987-09-23 | Pfizer Ltd | Antiarrythmic agents |
US4882337A (en) * | 1988-08-12 | 1989-11-21 | Pfizer Inc. | Tetrahydroisoquinoline antiarrhythmic agents |
US5304554A (en) * | 1990-04-27 | 1994-04-19 | Emory University | 4-[(alkyl or dialkyl)amino]quinolines and their method of preparation |
US5270323A (en) * | 1990-05-31 | 1993-12-14 | Pfizer Inc. | Method of treating impotence |
PT100905A (pt) * | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
TW304945B (ko) * | 1992-06-27 | 1997-05-11 | Hoechst Ag | |
RU2118322C1 (ru) * | 1993-07-05 | 1998-08-27 | Дюфар Интернэшнл Рисерч Б.В. | 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли |
US6143746A (en) * | 1994-01-21 | 2000-11-07 | Icos Corporation | Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use |
GB9514465D0 (en) * | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Chemical compounds |
GB9514464D0 (en) | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Medicaments |
GB9514473D0 (en) | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Chemical compounds |
GB9526546D0 (en) | 1995-12-23 | 1996-02-28 | Pfizer Ltd | Compounds useful in therapy |
HUP9901478A3 (en) * | 1996-05-10 | 1999-11-29 | Icos Corp Bothell | Carboline derivatives, their use, production thereof and medicaments containing the same |
GB9700504D0 (en) | 1997-01-11 | 1997-02-26 | Pfizer Ltd | Pharmaceutical compounds |
GB9708917D0 (en) * | 1997-05-01 | 1997-06-25 | Pfizer Ltd | Compounds useful in therapy |
GB9711650D0 (en) * | 1997-06-05 | 1997-07-30 | Pfizer Ltd | Compounds useful in therapy |
EP1301484A2 (en) | 2000-07-20 | 2003-04-16 | Neurogen Corporation | Capsaicin receptor ligands |
DE10035928A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
EP1178036A1 (en) * | 2000-08-04 | 2002-02-06 | Aventis Cropscience S.A. | Fungicidal phenylimidate derivatives |
US6900220B2 (en) | 2001-01-02 | 2005-05-31 | Syntex (U.S.A.) Llc | Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists |
KR100420663B1 (ko) * | 2001-01-09 | 2004-03-02 | 주식회사 켐온 | 퀴놀린 유도체, 그의 제조방법 및 그를 포함하는 약학적조성물 |
US6734303B2 (en) | 2001-05-18 | 2004-05-11 | Pfizer Inc. | Process for the production of quinazolines |
CA2468015A1 (en) * | 2001-11-27 | 2003-06-05 | Merck & Co., Inc. | 2-aminoquinoline compounds |
AU2013211455B2 (en) * | 2005-09-19 | 2017-12-07 | Neuronascent, Inc. | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
KR101158568B1 (ko) * | 2005-09-19 | 2012-07-02 | 뉴로내슨트, 아이엔씨. | 신경발생을 자극 및 신경 퇴화를 억제하는 방법 및 조성물 |
US8148398B2 (en) * | 2006-12-06 | 2012-04-03 | Cornell Research Foundation, Inc. | Intermediate duration neuromuscular blocking agents and antagonists thereof |
US8592451B2 (en) | 2009-03-17 | 2013-11-26 | Cornell University | Reversible nondepolarizing neuromuscular blockade agents and methods for their use |
US9220700B2 (en) | 2009-08-19 | 2015-12-29 | Cornell University | Cysteine for physiological injection |
AU2013277154A1 (en) | 2012-06-20 | 2014-12-18 | Jonathan E. Grob | Complement pathway modulators and uses thereof |
TWI649308B (zh) * | 2013-07-24 | 2019-02-01 | 小野藥品工業股份有限公司 | 喹啉衍生物 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB890533A (en) * | 1959-11-09 | 1962-03-07 | Allen & Hanburys Ltd | Improvements in or relating to heterocyclic quaternary ammonium salts |
CH414637A (de) * | 1962-08-31 | 1966-06-15 | Geigy Ag J R | Verfahren zur Herstellung von Carbostyrilderivaten |
US3272824A (en) * | 1962-12-06 | 1966-09-13 | Norwich Pharma Co | 4-amino-6, 7-di(lower) alkoxyquinolines |
US3542785A (en) * | 1967-05-15 | 1970-11-24 | Ciba Geigy Corp | 2-hydroxy-4-aryl-quinolines |
US3517005A (en) * | 1967-10-26 | 1970-06-23 | Pfizer & Co C | Certain 2- and 4-substituted quinazolines |
US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
US3629418A (en) * | 1969-02-14 | 1971-12-21 | Miles Lab | Process for producing an anti-depressant effect with piperazine quinolines |
GB1383409A (en) * | 1972-09-09 | 1974-02-12 | Pfizer Ltd | Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them |
US4035367A (en) * | 1974-09-09 | 1977-07-12 | Sandoz, Inc. | Hydroxyalkyl-substituted-amino-quinolines |
US4188390A (en) * | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
JPS54125688A (en) * | 1978-02-27 | 1979-09-29 | Mitsubishi Yuka Yakuhin Kk | Novel quinazoline derivative*its manufacture and antihypertensive drug |
JPS5480372A (en) * | 1977-12-12 | 1979-06-27 | Toray Ind Inc | Production of fishing rod made of carbon fiber-reinforced resin |
JPS54122283A (en) * | 1978-03-13 | 1979-09-21 | Sumitomo Chem Co Ltd | Novel quinazoline derivative and its preparation |
JPS54128588A (en) * | 1978-03-29 | 1979-10-05 | Dainippon Pharmaceut Co Ltd | Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline |
JPS54128582A (en) * | 1978-03-30 | 1979-10-05 | Sumitomo Chem Co Ltd | Novel quinazoline derivative and its preparation |
US4287341A (en) * | 1979-11-01 | 1981-09-01 | Pfizer Inc. | Alkoxy-substituted-6-chloro-quinazoline-2,4-diones |
DE3034001A1 (de) * | 1980-09-10 | 1982-04-22 | Hoechst Ag, 6000 Frankfurt | Isochinolinderivate, verfahren zu ihrer hersellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung |
-
1983
- 1983-07-19 GR GR71969A patent/GR79603B/el unknown
- 1983-07-19 US US06/515,095 patent/US4656174A/en not_active Expired - Lifetime
- 1983-07-20 DE DE8383304196T patent/DE3371336D1/de not_active Expired
- 1983-07-20 EP EP83304196A patent/EP0100200B1/en not_active Expired
- 1983-07-21 ES ES524320A patent/ES8504131A1/es not_active Expired
- 1983-07-21 FI FI832658A patent/FI78296C/fi not_active IP Right Cessation
- 1983-07-21 PL PL1983243131A patent/PL139498B1/pl unknown
- 1983-07-22 ZA ZA835355A patent/ZA835355B/xx unknown
- 1983-07-22 IL IL69311A patent/IL69311A/xx not_active IP Right Cessation
- 1983-07-22 IE IE1730/83A patent/IE55798B1/en not_active IP Right Cessation
- 1983-07-22 AU AU17222/83A patent/AU548036B2/en not_active Expired
- 1983-07-22 YU YU1572/83A patent/YU42628B/xx unknown
- 1983-07-22 DK DK337383A patent/DK166821B1/da not_active IP Right Cessation
- 1983-07-22 CS CS835509A patent/CS247073B2/cs unknown
- 1983-07-22 PT PT77082A patent/PT77082B/pt unknown
- 1983-07-22 KR KR1019830003392A patent/KR880001315B1/ko not_active IP Right Cessation
- 1983-07-22 HU HU832594A patent/HU190907B/hu unknown
- 1983-07-22 JP JP58134244A patent/JPS5933264A/ja active Granted
- 1983-07-22 CA CA000433023A patent/CA1255670A/en not_active Expired
- 1983-07-22 DD DD83253330A patent/DD211555A5/de not_active IP Right Cessation
- 1983-07-22 SU SU833618703A patent/SU1251801A3/ru active
- 1983-07-22 NO NO832688A patent/NO171594C/no not_active IP Right Cessation
- 1983-07-22 NZ NZ204996A patent/NZ204996A/en unknown
- 1983-07-25 PH PH29286A patent/PH19424A/en unknown
-
1984
- 1984-04-26 SU SU843732816A patent/SU1340589A3/ru active
-
1986
- 1986-10-30 US US06/925,029 patent/US4686228A/en not_active Expired - Lifetime
-
1987
- 1987-05-11 US US07/048,343 patent/US4758568A/en not_active Expired - Lifetime
-
1989
- 1989-02-04 SG SG64/89A patent/SG6489G/en unknown
- 1989-04-20 HK HK322/89A patent/HK32289A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR840005428A (ko) | 4-아미노-6, 7-디메톡시퀴놀린 유도체의 제조방법 | |
KR850003402A (ko) | 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법 | |
KR830000679A (ko) | N-알킬화 아미노알콜의 제조방법 | |
KR860001104A (ko) | 테트라히드로프탈이미드의 제조방법 | |
KR860001110A (ko) | 항균제 ⅱ의 제법 | |
KR840001949A (ko) | 신규 펩티드 화합물의 제법 | |
KR850006386A (ko) | 아졸류의 제조방법 | |
ES2004386A6 (es) | Un procedimiento para producir un nuevo derivado de difluorohalometoxifenilo | |
SE8703169D0 (sv) | 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5h-2,3-benzodiazepine, acid addition salts thereof and process for preparing same | |
ES557198A0 (es) | Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina | |
KR860000243A (ko) | 아민유도체의 제조방법 | |
AR246257A1 (es) | Procedimientos para preparar compuestos piperidinilicos 1,4-disustituidos, utiles como antiarritmicos, analgesicos y antagonistas del efecto de serotonina sobre los receptores 5ht2. | |
KR830007626A (ko) | 2-(1,4-벤조디옥산-2-일알킬) 이미다졸류의 제조방법 | |
KR840004422A (ko) | 사이프로헵타딘-3-카복실산의 에스테르 및 관련 화합물의 제조방법 | |
KR840004065A (ko) | 2-시아노-2-프로페노산 및 그 유도체의 제조방법 | |
KR840001165A (ko) | 시드논 이민 유도체의 제조방법 | |
KR850003407A (ko) | 유기인산 에스테르 유도체의 제조방법 | |
KR840000901A (ko) | 옥센돌론 수성 현탁제의 제조방법 | |
KR840005726A (ko) | 고혈압 치료제로서 유용한 치환페닐 피페라진 화합물의 제조방법 | |
KR850000034A (ko) | 테트라하이드로-β-카르보린 유도체의 제조방법 | |
ATE36520T1 (de) | Polyprenylverbindung, ihre herstellung und pharmazeutische verwendung. | |
KR850006933A (ko) | 설파모일-치환된 펜에틸아민 유도체의 제조방법 | |
ES543790A0 (es) | Procedimiento de preparacion de nuevos derivados a-etilami- noetoxibencilalcoholicos con un grupo fenil sustituido en situacion a y de sus sales de adicion acidas y amonicas cua-ternarias | |
KR850001742A (ko) | 큐말산 에스테르의 제조방법 | |
ES2034252T3 (es) | Procedimiento para la preparacion de compuestos macrolidos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20020708 Year of fee payment: 15 |
|
EXPY | Expiration of term |